Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maximizing Exercise Effectiveness in Fibromyalgia
NCT00535587Phase 2Completed
- Sponsor
- Oregon Health & Science University
- Start
- Sep 2002
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pyridostigmine in fibromyalgia (FM), sponsored by Oregon Health & Science University. Started Sep 2002; status: completed.
02
Drugs
pyridostigmine
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00535587.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00535587.